OUR STAFF REPORTER RAWALPINDI - The pharmaceutical industry has been facing immense problems owing to shifting of the Health Ministry from the federal level to the provinces under the 18th Amendment. The Secretary Health, with the support of self acclaimed and notorious association of Pakistan Pharmaceutical Manufacturers Association (PPMA) and multi-national pharma companies, was manipulating the current situation, which was not only adding to the sufferings of local companies but also discouraging the new investors to invest in the country. These views were expressed by Rawalpindi Chamber of Commerce and Industry (RCCI) President Syed Ali Raza Saeed Shah at a press conference held here in Chamber on Monday. RCCI Chairman Standing Committee for Pharmaceutical Muhammad Aslam, former president Najam Rehan, Traders Association of Cantt President Sheikh Hafeez and M Saleem Qureshi along with other members were also present on the occasion. The RCCI president also demanded Prime Minister Syed Yousuf Raza Gilani to take immediate notice of the prevailing situation, otherwise, more than 100 of pharmaceutical companies would be closed down in Rawalpindi and this could affect the investment of billions of rupees in the country. Raza stressed that corrupt bureaucracy and mafia was creating hurdles in the ways of investors at a time when country was desperately looking for investment. Although the local investors have the offers from the neighbouring and other countries to invest in their countries but being Pakistani they want to invest in Pakistan for the benefit of their homeland, he said. The RCCI president said that some investors had invested billion of rupees in pharma industry but the government without mulling and consultation shifted the ministry to the provinces, putting huge investment made by the industrialists in the doldrums. He said that in the game of using power against each other political appointments and bureaucracy neglect the investors. He further said that government has failed to establish Drug Registration Authority (DRA) and did not produce any clear policy regarding the issue. To avoid issuance of new licenses to the new pharmaceutical companies registration meetings are being postponed on regular basis, he added. He said that due to the involvement of the multinational companies almost 20,000 products registration cases are awaiting approval. He said that RCCI is planning to meet the Prime Minister to resolve the issue and soon future plan would be chalked out.